Residual or retained gadolinium: practical implications for radiologists and our patients.
From the Department of Radiology, University of Pittsburgh Medical Center, Room D132, 200 Lothrop St, Pittsburgh, PA 15213-2582 (E.K.); and the Department of Radiology and James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.
Emanuel
E
Kanal
Michael F
MF
Tweedle
D001921:Brain / Q000378:metabolism*; D002529:Cerebellar Nuclei / Q000378:metabolism*; D003287:Contrast Media / Q000493:pharmacokinetics*; D005260:Female; D005682:Gadolinium / Q000493:pharmacokinetics*; D019786:Gadolinium DTPA / Q000493:pharmacokinetics*; D005917:Globus Pallidus / Q000378:metabolism*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008536:Meglumine / Q000493:pharmacokinetics*; D009942:Organometallic Compounds / Q000493:pharmacokinetics*
D003287:Contrast Media; D009942:Organometallic Compounds; D008536:Meglumine; D005682:Gadolinium; D019786:Gadolinium DTPA